Cargando…
Proteomic aptamer analysis reveals serum markers that characterize preclinical systemic sclerosis (SSc) patients at risk for progression toward definite SSc
BACKGROUND: The study of molecular mechanisms characterizing disease progression may be relevant to get insights into systemic sclerosis (SSc) pathogenesis and to intercept patients at very early stage. We aimed at investigating the proteomic profile of preclinical systemic sclerosis (PreSSc) via a...
Autores principales: | Bellocchi, Chiara, Assassi, Shervin, Lyons, Marka, Marchini, Maurizio, Mohan, Chandra, Santaniello, Alessandro, Beretta, Lorenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881382/ https://www.ncbi.nlm.nih.gov/pubmed/36707842 http://dx.doi.org/10.1186/s13075-023-02989-w |
Ejemplares similares
-
Reactome pathway analysis from whole-blood transcriptome reveals unique characteristics of systemic sclerosis patients at the preclinical stage
por: Bellocchi, Chiara, et al.
Publicado: (2023) -
Preliminary safety and efficacy profile of prucalopride in the treatment of systemic sclerosis (SSc)-related intestinal involvement: results from the open label cross-over PROGASS study
por: Vigone, Barbara, et al.
Publicado: (2017) -
Supersymmetry at the SSC
por: Ellis, Jonathan Richard
Publicado: (1985) -
Supercollider: SDC for SSC
Publicado: (1992) -
Supercollisionneur : SSC Preparatifs
Publicado: (1990)